Charles River Laboratories (CRL)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 227,347 | 617,261 | 650,975 | 589,862 | 432,729 |
| Revenue | US$ in thousands | 4,120,490 | 4,082,940 | 4,098,090 | 3,457,220 | 2,939,570 |
| Operating profit margin | 5.52% | 15.12% | 15.88% | 17.06% | 14.72% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $227,347K ÷ $4,120,490K
= 5.52%
The operating profit margin of Charles River Laboratories has shown some fluctuations over the five-year period from December 31, 2020, to December 31, 2024.
- Between December 31, 2020, and December 31, 2021, the operating profit margin improved from 14.72% to 17.06%, indicating an enhancement in operational efficiency or cost management during this period.
- However, there was a slight decrease in the operating profit margin from December 31, 2021, to December 31, 2022, where it dropped to 15.88%. This may suggest a potential increase in operating expenses or a decline in revenue growth.
- By December 31, 2023, the operating profit margin further decreased to 15.12%, possibly indicating ongoing challenges in maintaining profitability.
- The operating profit margin experienced a significant decline to 5.52% by December 31, 2024, which raises concerns about the company's ability to generate profits from its core operations effectively.
In conclusion, the trend in Charles River Laboratories' operating profit margin shows initial improvement followed by subsequent declines, with a notable decrease in the most recent period. Further analysis of the company's financial performance and operational strategies may be needed to address the declining trend in the operating profit margin.
Peer comparison
Dec 31, 2024